Woodline Partners »

Jasper Therapeuritc shares owned by Woodline Partners

Quarter-by-quarter ownership of Jasper Therapeuritc (JSPR) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Jasper Therapeuritc

Tip: Access up to 7 years of quarterly data

All positions including Jasper Therapeuritc held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jasper Therapeuritc by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $11M 379k 29.36

More positions owned by Woodline Partners

Eli Lilly & Co. (LLY)
Te Connectivity SHS (TEL)
Regeneron Pharmaceuticals (REGN)
Encana Corporation (OVV)
Analog Devices (ADI)
Avnet (AVT)
Merck & Co (MRK)
Revolution Medicines (RVMD)
Zimmer Holdings (ZBH)
Meta Platforms Cl A (META)
Roivant Sciences SHS (ROIV)
Abbvie (ABBV)
Enerplus Corp (ERF)
Permian Resources Corp Class A Com (PR)
Amazon (AMZN)

View all positions for Woodline Partners

Top funds holding Jasper Therapeuritc

Velan Capital Investment Management
Soleus Capital Management
Carlyle
Avidity Partners Management
Franklin Resources
Vanguard Group
Samsara BioCapital
Sphera Funds Management
Octagon Capital Advisors
Kingdon Capital Management
Opaleye Management
Dr. Jeffrey R. Jay, M.D.
Rock Springs Capital Management
Woodline Partners
Boxer Capital

View all funds holding Jasper Therapeuritc